KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maxlinear (MXL) EBT Margin (2016 - 2025)

Historic EBT Margin for Maxlinear (MXL) over the last 17 years, with Q4 2025 value amounting to 13.05%.

  • Maxlinear's EBT Margin rose 312400.0% to 13.05% in Q4 2025 from the same period last year, while for Dec 2025 it was 30.13%, marking a year-over-year increase of 360800.0%. This contributed to the annual value of 30.13% for FY2025, which is 360800.0% up from last year.
  • As of Q4 2025, Maxlinear's EBT Margin stood at 13.05%, which was up 312400.0% from 34.31% recorded in Q3 2025.
  • In the past 5 years, Maxlinear's EBT Margin ranged from a high of 17.06% in Q1 2022 and a low of 101.72% during Q3 2024
  • Moreover, its 5-year median value for EBT Margin was 8.3% (2021), whereas its average is 18.52%.
  • As far as peak fluctuations go, Maxlinear's EBT Margin plummeted by -878500bps in 2024, and later surged by 674100bps in 2025.
  • Quarter analysis of 5 years shows Maxlinear's EBT Margin stood at 11.49% in 2021, then rose by 22bps to 14.01% in 2022, then tumbled by -343bps to 34.01% in 2023, then crashed by -30bps to 44.29% in 2024, then soared by 71bps to 13.05% in 2025.
  • Its last three reported values are 13.05% in Q4 2025, 34.31% for Q3 2025, and 28.21% during Q2 2025.